Philips introduces system for integrated nuclear medicine, radiation oncology
Royal Philips Electronics has released its new BrightView XCT, designed to meet the needs of nuclear medicine, which is on display at the Society of Nuclear Medicine (SNM) meeting in New Orleans, held June 14-18.
The BrightView XCT integrates Philips BrightView SPECT in a co-planar design with advanced flat-detector x-ray CT technology to acquire low-dose, high-resolution CT images and to improve registration confidence. This is the first time a flat panel x-ray detector will be used for CT imaging in nuclear medicine, according to Philips Healthcare.
Philips said its system, along with the new Gemini TF Big Bore and new nuclear medicine Application Portfolio on the Extended Brilliance Workspace is currently on display at their SNM booth.
“At SNM 2008, we are adding to our history of clinical innovation with several new products, demonstrating how Philips is combining design, technology and intelligence in ways specifically designed to help our customers do more for their patients in general nuclear medicine studies and throughout the cycle of care in oncology and cardiology,” said Jay Mazelsky, senior vice president of nuclear medicine, for Philips.
The BrightView XCT integrates Philips BrightView SPECT in a co-planar design with advanced flat-detector x-ray CT technology to acquire low-dose, high-resolution CT images and to improve registration confidence. This is the first time a flat panel x-ray detector will be used for CT imaging in nuclear medicine, according to Philips Healthcare.
Philips said its system, along with the new Gemini TF Big Bore and new nuclear medicine Application Portfolio on the Extended Brilliance Workspace is currently on display at their SNM booth.
“At SNM 2008, we are adding to our history of clinical innovation with several new products, demonstrating how Philips is combining design, technology and intelligence in ways specifically designed to help our customers do more for their patients in general nuclear medicine studies and throughout the cycle of care in oncology and cardiology,” said Jay Mazelsky, senior vice president of nuclear medicine, for Philips.